基于价值医疗的抗肿瘤药物精细化管理实践  

Practice of refined management of anti-tumor drugs based on value healthcare

作　　者：邱慧 金晔萍 杨敏[1] 夏宗玲[2] 陈荣[2] 王莉英[2] 薛海翔[3] 李莉[3] 邵东[4] Qiu Hui;Jin Yeping;Yang Min;Xia Zongling;Chen Rong;Wang Liying;Xue Haixiang;Li Li;Shao Dong(Department of Medical,First People′s Hospital of Changzhou,Changzhou 213003,China;Department of Pharmacy,First People′s Hospital of Changzhou,Changzhou 213003,China;Office of Discipline Supervision Investigation,First People′s Hospital of Changzhou,Changzhou 213003,China;Office of Medical Insurance,First People′s Hospital of Changzhou,Changzhou 213003,China)

机构地区：[1]常州市第一人民医院医务处,常州213003 [2]常州市第一人民医院药学部,常州213003 [3]常州市第一人民医院纪检监察室,常州213003 [4]常州市第一人民医院医疗保险办公室,常州213003

出　　处：《中华医院管理杂志》2023年第1期46-50,共5页Chinese Journal of Hospital Administration

摘　　要：近年来,我国癌症治疗费用的快速增长给社会带来巨大经济负担,规范抗肿瘤药物合理应用刻不容缓。在疾病诊断相关分组支付改革背景下,2018年12月,某三级甲等医院以患者需求为中心,以价值医疗为导向,建立了专业化和常态化的抗肿瘤药物精细化管理体系,组建多学科诊疗团队,推进"互联网+药学服务"。2019—2021年医院药占比分别为30.8%、30.1%和27.3%,抗肿瘤药物使用金额分别为8325万元、7641万元和6248万元,呈逐年下降趋势。抗肿瘤药物精细化管理实践充分体现了价值医疗以人为本的核心理念,实现了全流程药物闭环管理,减轻了患者经济负担,为提高公立医院抗肿瘤药物合理用药水平提供参考。In recent years,the rapid increase in cancer treatment costs in China had brought a huge economic burden to society,and it was urgent to standardize the rational application of anti-tumor drugs.In the context of the reform of group payment related to disease diagnosis,a tertiary first-class hospital focused on the needs of patients and guided by value-based healthcare,established a professional and normalized refined anti-tumor drug management system,setted up a multidisciplinary diagnosis and treatment team,and promoted"Internet plus pharmaceutical services"in December 2018.From 2019 to 2021,the proportion of hospital drugs were 30.8%,30.1%,and 27.3%,respectively.The amount of money spent on anti-tumor drugs were 83.25 million yuan,76.41 million yuan,and 62.48 million yuan,respectively,showing a decreasing trend year by year.The practice of refined management of anti-tumor drugs fully reflected the core concept of value based healthcare,achieving closed-loop management of the entire process of drugs,improving the level of rational drug use,reducing the economic burden on patients,and providing reference for improving the level of rational use of anti-tumor drugs in public hospitals.

关 键 词：精细化管理 疾病诊断相关分组 价值医疗 抗肿瘤药物 多学科诊疗 

分 类 号：R954[医药卫生—药学]